| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-07 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.22 | 4e-07 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-06 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-06 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.18 | 7e-06 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-06 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.27 | 9e-06 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-05 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.26 | 3e-05 |